AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹922 Cr | ₹837 Cr | ₹796 Cr | ₹949 Cr | ₹940 Cr |
What is the latest Total Current Liabilities ratio of AARTI DRUGS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹922 Cr |
| Mar2025 | ₹837 Cr |
| Mar2024 | ₹796 Cr |
| Mar2023 | ₹949 Cr |
| Mar2022 | ₹940 Cr |
How is Total Current Liabilities of AARTI DRUGS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹922 Cr | 10.19 | |
| Mar2025 | ₹837 Cr | 5.21 | |
| Mar2024 | ₹796 Cr | -16.21 | |
| Mar2023 | ₹949 Cr | 1.00 | |
| Mar2022 | ₹940 Cr | - | |
Compare Total Current Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,619.6 Cr | -4.3% | -6.5% | -23.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -4.3% |
-6.5% |
-23.5% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses